Custom CRISPR Cell Line Engineering Services

Harness the power of CRISPR through custom engineered cell line that expresses the desired genomic alterations

Custom CRISPR Cell Line Engineering Services: Tailoring Genomic Alterations to Your Needs

Heterologously expressed targets in stable cell lines are powerful tools for discovering small molecule and antibody drug leads. Assays from these cell lines are robust, reliable and target-specific. Before moving drug candidates into animal models and human trials, translational in vitro assays are much desired intermediate steps. These assays utilize endogenously expressed targets in physiologically relevant cells. However, the challenge is target-specificity. Since related proteins from the same family as the target of interest may signal in the same pathways, the results can be confounding from these native cells. This is where gene-editing is needed.

CRISPR technologies have revolutionized cell engineering by introducing genetic mutations and deletions with precision.

The possibility of generating isogenically CRISPR-modified native stable cell lines along with the wildtype or parental cells are opening up a myriad of possibilities for assay development. Assays from these paired cell lines are properly controlled to pinpoint the target-specific effect. They enhance the biology relevance in cell-based assays without losing data quality. Consequently, they can serve to bridge in vitro and in vivo studies, impacting target discovery, target validation, and drug discovery screening by saving time and cost.

CRISPR technologies have risen as a game-changer in biotech research, especially in the domain of Cell Line Engineering Services. By introducing genetic mutations, insertions and deletions with pinpoint precision, CRISPR has revolutionized cell engineering.

One of the most innovative offerings of Cell Line Engineering Services is the capability to generate isogenically CRISPR-modified native stable cell lines. When paired alongside their wildtype or parental counterparts, these engineered cell lines are transforming assay development. The meticulous control achieved in assays derived from these cell lines allows researchers to attribute effects directly to target-specific modifications. Such advancements underscore the unparalleled value of Cell Line Engineering Services in contemporary biotechnological research.

Multispan Cell Line Engineering Services Expertise

Embracing CRISPR-modified cell lines through Cell Line Engineering Services ensures not only high data fidelity but also the reflection of authentic biological processes. This alignment between in vitro and in vivo studies proves invaluable in areas like target discovery, validation, drug discovery screening and preclinical studies. With the promise of reduced time, cost, and enhanced precision, Cell Line Engineering Services equipped with CRISPR technologies are poised to be indispensable tools for modern researchers.

In conclusion, as we venture further into the era of genomic customization, the pivotal role of Cell Line Engineering Services, bolstered by CRISPR technologies, cannot be overstated. For those seeking precision, efficiency, and reliability, the future of cell line engineering is here, and it’s tailored to meet diverse genomic needs.

Multispan’s Enhanced MULTISCREENTM CRISPR Gene-Editing Platform: The Pinnacle of Cell Line Engineering Services

Distinguished by its unparalleled innovation, MULTISCREENTM CRISPR gene-editing platform seamlessly merges expansive expertise across assay development, cell engineering, and cloning. Upholding the reputation of MULTISCREENTM cell lines, we prioritize quality above all, ensuring that our CRISPR gene-edited stable cell lines stand out in the market of Cell Line Engineering Services. Our commitment to excellence is reflected in our focus.

Cell Stability

Meticulous single-cell cloning, reinforcing the longevity and reliability of our engineered lines.

Assay Performance

Directly screening in functional assays, we ensure that our cell lines deliver consistent and robust results, streamlining your research process.

Quality Control

Rigorous checks on expression and function post-cell banking, guaranteeing that our cell lines not only meet but exceed industry standards in Cell Line Engineering Services.

Harnessing Advanced Cell Line Engineering Services: A Collaborative Approach with CRISPR Expertise

Initiating our robust Cell Line Engineering Services, we join forces with leading CRISPR nuclease technology experts, ensuring the premium quality of gRNA design and optimization. Simultaneously, we define the disease-biology relevant cell line and the appropriate signaling pathway or phenotype for the initial assay. Parental cell lines may originate from specific tumors such as lung, pancreas, liver, kidney, ovary, breast, nerve, and bone. Our assays, tailored for precision, can be founded on signaling 2nd messenger, reporter, phenotype, or binding with fluorescence, TR-FRET, and chemiluminescence readouts. For G-protein Coupled Receptors (GPCRs), our Cell Line Engineering Services and cell banking services, have given rise to a plethora of cell-based assays, including but not limited to Ca++, cAMP, β-arrestin, pGRK2, IP-1, pERK, pNFκB, cell proliferation, internalization and luciferase reporter.

Following the transfection of CRISPR-gRNA, a stable pool of cells is typically ready for testing within a 2-week frame. However, the inherent heterogeneity of these cells renders them unsuitable for long-term drug discovery projects where data consistency over prolonged periods is paramount. Addressing this challenge, the Multispan team, with over a century of collective experience in cell sciences and signaling, employs our specialized Cell Line Engineering Services to produce cell lines renowned for their stability, enduring for decades when appropriately preserved.

How do we pick the CRISPR-edited single cell clones?

By functional assay directly! Based on functional efficacy, heterozygous or homozygous stable cell lines can be detected and selected at the same time. The change of expression of the targets in the engineered clones will be further validated by flow-cytometry, western blotting, or RT-PCR. We have a 100% success rate for the generation of quality clonal stable cell lines for >500 targets. Furthermore, these highly characterized stable cell lines can be seamlessly integrated into our scaleup cell banking and compound screening services, which makes fast compound screening data turnaround possible. 

Interested in assay-ready CRISPR-edited stable cell lines for high throughput screening to propel drug discovery? Multispan can help!

Want to learn more or can't find what you are looking for?
Request a scientific consultation.